文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

血栓弹力图MA-R比值与创伤患者死亡率的关系

Clot dynamics and mortality: The MA-R ratio.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论入院血栓弹力图MA/R比值最低的创伤患者死亡风险最高,该比值可能有助于早期识别高危患者。

本研究在两家一级创伤中心纳入330例符合最高激活标准且24小时内接受至少1单位浓缩红细胞的创伤患者,计算入院血栓弹力图MA除以R时间所得MA-R比值并按四分位分组。多变量分析控制损伤机制、损伤严重度评分和入院pH后,MA-R比值升高与死亡 odds 降低相关。最低MA-R比值组损伤严重度评分更高、钝性伤比例更高、血浆使用量更大,而浓缩红细胞输注量无显著差异。作者认为低MA-R比值可能反映纤维蛋白原耗竭导致血凝块强度减弱,此类患者或可从早期冷沉淀输注中获益,而非传统大量输血方案中的血浆。

要点

  • 在330例创伤患者中,入院MA-R比值最低四分位组死亡率最高,比值升高与死亡 odds 降低独立相关。
  • 最低MA-R比值组同时损伤严重度评分更高、钝性伤比例更高、血浆使用量更大,浓缩红细胞用量无显著差异。
  • 作者认为低MA-R比值可能由纤维蛋白原耗竭导致血凝块强度减弱所致。
  • 作者建议低MA-R比值患者或可考虑早期冷沉淀复苏,而非当前大量输血方案中传统的血浆使用。
  • 该比值可能在其他生理指标尚未异常时早期识别有创伤性凝血病风险的患者。

适用人群与场景

  • 经两家一级创伤中心最高激活标准收治、且入院24小时内接受至少1单位浓缩红细胞的创伤患者。
  • 研究纳入330例有入院血栓弹力图结果的患者,中位年龄35岁(四分位距25-54岁),中位损伤严重度评分20(四分位距13-29),76%为男性,43%为穿透伤。

诊断标准与关键阈值

  • MA-R比值计算方法:血栓弹力图最大振幅(MA)除以R时间。
  • MA-R比值按四分位分组,最低四分位组死亡风险最高。

研究设计与关键结果

  • 研究类型为预后研究,证据等级为Level I。
  • 共纳入330例患者,来自两家一级创伤中心。
  • 多变量逻辑回归控制损伤机制、损伤严重度评分和入院pH后,MA-R比值升高与死亡 odds 降低相关。
  • 最低MA-R比值组与更高的损伤严重度评分、更高的钝性伤比例和更高的血浆使用量显著相关,而浓缩红细胞输注量无显著差异。
  • 最低MA-R比值组死亡率最高。

证据类型、等级与局限

  • 证据类型:预后研究,证据等级Level I。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,低MA-R比值可能有助于在其他生理指标尚未异常时早期预测有创伤性凝血病风险的患者。
  • 作者认为,低MA-R比值患者或可受益于早期冷沉淀复苏,而非当前大量输血方案中传统的血浆使用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The coagulopathy of trauma, illustrated by a short R-time, is common and well understood. The physiology behind this may be early thrombin burst with rapid clot formation. Rapid consumption of fibrinogen, however, may result in weak clot and substrate depletion, resulting in low MA. While these characteristics are interesting, utilizing thromboelastography (TEG) to identify those at risk of subsequent bleeding diathesis, especially in those who do not demonstrate early signs of physiologic derangement, is challenging. We have developed a novel ratio utilizing TEG values to describe patients at specific risk of traumatic coagulopathy. The purpose of this study was to create a single TEG value, which would reflect both the hypercoagulability and hypocoagulability of TIC. We hypothesized that this ratio, at admission, would be indicative of TIC and predictive of both blood product transfusion volumes and subsequent mortality.

METHODS: Patients admitted via the highest activation criteria at one of two Level I trauma centers were included if they received at least 1 unit of packed red blood cells in the first 24 hours of admission. The admission TEG was collected, and a ratio was calculated by dividing the MA by the R-time (MA-R). MA-R quartiles were developed, and multivariable logistic regression was utilized to determine odds of mortality.

RESULTS: Three hundred thirty patients with admission TEG were included. In all patients, median age was 35 years (interquartile range, 25-54 years), Injury Severity Score (ISS) was 20 (interquartile range, 13-29), 76% were male, and 43% had penetrating trauma. The MA-R groups were based on quartiles. Multivariable analysis, controlling for mechanism of injury, ISS, and admission pH, showed that increasing ratios were associated with decreased odds of death. The lowest MA-R ratios were also significantly associated with higher ISS, higher rates of blunt injury, and higher plasma utilization without a significant difference in packed red blood cell administration.

CONCLUSIONS: Patients with the lowest MA-R ratios demonstrated the highest mortality rates. This novel ratio may prove highly useful to predict at-risk patients early, when other physiologic indicators are absent. The mechanism driving this finding may rest in fibrinogen depletion, resulting in weak clot. Patients with low MA-R ratios may benefit from earlier resuscitation with cryoprecipitate, rather than the traditional use of plasma found in current massive transfusion protocols.

LEVELS OF EVIDENCE: Prognostic study, Level I.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Savage SA, Zarzaur BL, Pohlman TH, et al. Clot dynamics and mortality: The MA-R ratio. J Trauma Acute Care Surg. 2017. PMID: 28930957. doi:10.1097/TA.0000000000001637

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。